openPR Logo
Press release

Biologics and Biosimilars Market 2021 Industry Scope, Future Expectations and Overview | Key Players -3sbio, Merck, Biotech, CP Guojian

09-16-2021 01:57 PM CET | Industry, Real Estate & Construction

Press release from: Market Insights Reports

Biologics and Biosimilars Market Research Report 2021 - 2025

Latest released, the research study on Global Biologics and Biosimilars Market Report Forecast 2021 - 2025, offers a detailed overview of the factors influencing the global business scope. Biologics and Biosimilars Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Biologics and Biosimilars. The study covers emerging player's data, including competitive landscape, sales, revenue and global market share of top manufacturers are: 3sbio, Merck, Biotech, CP Guojian, United Laboratories, Eli Lilly, Novo Nordisk, Roche, AbbVie, Gelgen, Sanofi-Aventis, Johnson & Johnson, Changchun High Tech, Innovent, Amgen, Pfizer, Dong Bao, Ganlee, Novartis

In 2020, the global Biologics and Biosimilars market size was US$ 182380 million and it is expected to reach US$ 260090 million by the end of 2027, with a CAGR of 5.1% during 2021-2027.

Click the link to Get a Free Exclusive Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/08182228739/covid-19-outbreak-global-biologics-and-biosimilars-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020/inquiry?mode=69

Market Overview:

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original innovator products, and can be manufactured when the original product's patent expires.
The major global manufacturers of biologics and biosimilars are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Sansheng Pharmaceuticals, Changchun Gaoxin, CITICS Guojia, Baitai Biotech, Sijin Biotech, Cinda Biotech, Tonghua Dongbao, Ganli and Union Pharmaceuticals, etc. Roche, Amgen and AbbVie are the top three, with a combined market share of about 37%.

This report elaborates the market size, market characteristics, and market growth of the Biologics and Biosimilars industry, and breaks down according to the type, application, and consumption area of Biologics and Biosimilars. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

Segmentation By Type:

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Segmentation By Application:

Tumor

Diabetes

Cardiovascular

Hemophilia

Regional Analysis:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Inquiry for Best Discount here:

https://www.marketinsightsreports.com/reports/08182228739/covid-19-outbreak-global-biologics-and-biosimilars-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020/discount?mode=69

Significant Features and Key Highlights of the Reports:

– Detailed overview of Biologics and Biosimilars Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc.
– Historical, current and projected market size in terms of volume and value.
– Recent industry trends and developments
– Competitive landscape of Biologics and Biosimilars Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.

Key questions answered:

- Who are the Leading key players and what are their Key Business plans in the Global Biologics and Biosimilars market?
- What are the key concerns of the five forces analysis of the Global Biologics and Biosimilars market?
- What are different prospects and threats faced by the dealers in the Global Biologics and Biosimilars market?
- What are the strengths and weaknesses of the key vendors?

Purchase Full Report @:

https://www.marketinsightsreports.com/report/purchase/08182228739?mode=su?mode=69

Customization of this Report: This report can be customized as per your needs for additional data up to 5 companies or countries or 40 analyst hours.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
Market Insights Reports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Market Insights Reports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics and Biosimilars Market 2021 Industry Scope, Future Expectations and Overview | Key Players -3sbio, Merck, Biotech, CP Guojian here

News-ID: 2395926 • Views: 222

More Releases from Market Insights Reports

Aerial Firefighting Market By Product Type, End-Users/Application, In-Depth Anal …
The Aerial Firefighting Market study inspects changing market trends, major segments, top investment pockets, value chain, competitive landscape, and regional scenario in great detail. The Aerial Firefighting Market studies analyses growth rate, product price, profit, capacity, production, supply, demand, market growth rate, and forecast through 2027 for the world's major regions. The Aerial Firefighting Market is expected to register a CAGR of 2.9% over the forecast period 2021 – 2027. The
Demolition Machines Market Study Offering Insights on Latest Advancements, Trend …
The Demolition Machines Market study inspects changing market trends, major segments, top investment pockets, value chain, competitive landscape, and regional scenario in great detail. The Demolition Machines Market studies analyses growth rate, product price, profit, capacity, production, supply, demand, market growth rate, and forecast through 2027 for the world's major regions. The Demolition Machines Market is expected to register a CAGR of 2.5% over the forecast period 2021 – 2027. The
Home Water Filtration Unit Market Research and Development with Growth Analysis …
The Home Water Filtration Unit Market study inspects changing market trends, major segments, top investment pockets, value chain, competitive landscape, and regional scenario in great detail. The Home Water Filtration Unit Market studies analyses growth rate, product price, profit, capacity, production, supply, demand, market growth rate, and forecast through 2027 for the world's major regions. The Home Water Filtration Unit Market is expected to register a CAGR of 15.4% over the
Marijuana Drying and Curing Equipment Market By Product Type, End-Users/Applicat …
The Marijuana Drying and Curing Equipment Market study inspects changing market trends, major segments, top investment pockets, value chain, competitive landscape, and regional scenario in great detail. The Marijuana Drying and Curing Equipment Market studies analyses growth rate, product price, profit, capacity, production, supply, demand, market growth rate, and forecast through 2027 for the world's major regions. The Marijuana Drying and Curing Equipment Market is expected to register a CAGR of

All 5 Releases


More Releases for Biosimilars

Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Global Biosimilars Market Research Report
This report studies the global Biosimilars market status and forecast, categorizes the global Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy’s Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 5 biosimilar version of Enbrel are commercially available in Iran, Mexico, India, UK and Australia. The patent on Enbrel was originally set to expire on